These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9120428)

  • 1. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M; Maruyama W; Dostert P; Hashizume Y
    J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
    Naoi M; Maruyama W; Kasamatsu T; Dostert P
    J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
    Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
    J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
    Naoi M; Maruyama W; Akao Y; Yi H
    Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
    Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
    Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death in Parkinson's disease.
    Maruyama W; Naoi M
    J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of idiopathic Parkinson's disease].
    Maruyama W
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
    Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
    Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
    Naoi M; Maruyama W
    Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
    [No Abstract]   [Full Text] [Related]  

  • 12. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
    J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl.
    Naoi M; Maruyama W; Takahashi T; Akao Y; Nakagawa Y
    J Neural Transm Suppl; 2000; (58):111-21. PubMed ID: 11128601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3.
    Akao Y; Nakagawa Y; Maruyama W; Takahashi T; Naoi M
    Neurosci Lett; 1999 Jun; 267(3):153-6. PubMed ID: 10380999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
    Maruyama W; Naoi M
    Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):333-42. PubMed ID: 11188501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
    Maruyama W; Strolin-Benedetti M; Naoi M
    Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
    Maruyama W; Abe T; Tohgi H; Naoi M
    Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
    Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
    J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.